Does Under-Eye Filler Help Eye Bags?

Eye bags and under-eye hollows get used interchangeably, but a 2012 review in Aesthetic Surgery Journal treats them as separate problems that can occur together or alone: lower-eyelid bags come from fat, while a tear-trough deformity is a hollow.

The treatments point in opposite directions.

Lower blepharoplasty removes excess fat, while tear-trough procedures add volume to the underlying depression.

The review lists hyaluronic acid filler, fat grafting, skeletal implants and fat transposition among the tear-trough options.

The American Society of Plastic Surgeons (ASPS) lists bags under the eyes and fatty deposits that appear as eyelid puffiness among the problems eyelid surgery treats — one marker of where fat-pad bags sit in the treatment landscape.

Filler's approved job under the eyes is filling a hollow.

As of October 2026, four US fillers carry an FDA-approved infraorbital (under-eye hollow) indication: Juvéderm Volbella XC (approved 2021-05-28), Restylane Eyelight (2023), Belotero Balance (+) Lidocaine (2023) and RHA Redensity Eye / Eye Lido (2026), all in adults.

Placing any other filler under the eyes — Restylane-L, Juvéderm Voluma XC, Radiesse and Sculptra are examples — is an off-label use: it is not on any current US label for those products.

Where a hollow and a bag occur together, filling the hollow adds volume to the depression beneath the bag — the move the 2012 review describes as the tear-trough treatment.

It does not change the fat pad itself, and we found no study measuring how much filling the hollow changes how the bag looks.

The Restylane Eyelight label limits treatment to up to 1 mL per side per session and recommends a follow-up session instead of a larger amount, because the safety of larger per-session amounts has not been established.

In a UK single-practice series of 1,452 tear-trough applications in 583 patients, the mean first-visit volume was 0.34 mL per eye, and larger volumes were significantly linked to swelling and contour irregularities.

The Restylane Eyelight label warns that people with a pre-existing tendency toward edema may get excessive swelling under the eyes from fluid build-up, that injection in people with pigmented dark lower-lid circles may make discoloration more prominent, and that too-superficial injection in thin under-eye skin may cause contour irregularities, palpable lumps and/or bluish discoloration.

The 2021 review of periocular fillers reports that 90% of adverse events around the eye are mild and self-resolve within 1 month — but malar edema, a delayed swelling unique to the under-eye area, occurred in 11% of patients and can be managed with hyaluronidase when an HA filler was used.

In the UK series, 10% reported swelling with a median duration of 4 weeks, 4.6% contour irregularities, 4.3% bruising and 3.3% a Tyndall effect (a bluish tint), and filler was dissolved in 1.9% of orbits.

Problems can also arrive late: a 2022 systematic review of 52 delayed complication cases after tear-trough filler found swelling was the most common (42.3%), with a mean onset of 16.8 months after injection.

We could not find any study that reports an overall rate at which under-eye filler makes bags look worse.

What the record supports is narrower: the label's swelling warnings and the published swelling figures above — with larger volumes raising the odds of edema and contour irregularities in the UK series.

If the result is puffiness or a lump, oculoplastic surgeons note that hyaluronidase is generally effective at reducing overcorrection or migration of HA filler under the eyes.

Dissolving filler is an off-label use of hyaluronidase, whose own label lists three approved uses unrelated to fillers.

For a true fat-pad bag, the option ASPS names is surgical.

ASPS lists bags under the eyes and fatty deposits that appear as eyelid puffiness among the problems eyelid surgery (blepharoplasty) treats.

Its cost pages give an average surgeon's fee of $3,876 for a lower blepharoplasty and $3,359 for an upper blepharoplasty, and ASPS notes these exclude anesthesia, operating-room facilities and other related expenses — so they are not the full price of surgery.

The 2012 review's non-filler tear-trough options are fat grafting, skeletal implants and fat transposition.

Cheek support is an approved treatment for the cheek, not for the eye bag.

Juvéderm Voluma XC, for example, is FDA-approved for cheek augmentation to correct age-related midface volume deficit.

No filler is approved to treat eye bags, and placing a cheek product under the eyes is off-label; we found no study we can cite on cheek filler for bags specifically.

Whether you are dealing with a bag, a hollow or both is the first question — the under-eye hollows guide walks through telling hollows, bags, dark circles and crepiness apart.

For the treatment itself, the under-eye filler guide covers the approved products, sessions, cost and injector choice.